Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2025 as attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries has submitted a routine compliance certificate to BSE under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 December 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited. It confirms that all share certificates received for dematerialisation during the quarter (1 October to 31 December 2025) were duly processed, confirmed to the depositories (NSDL and CDSL), mutilated/cancelled after verification, and the depository's name was substituted in the register of members within the required 15-day timeline. No specific share quantity or financial figures are disclosed in the filing.
This is a purely procedural regulatory filing with no impact on business operations, financials, or shareholder value. Investors can ignore it as it simply evidences that the company's share transfer records are in good standing.